tirzepatide heart failure trial Weight-loss drug may lower deaths Lilly says weight loss drug

Injectable Wegovy has demonstrated approximately 15% weight loss in clinical trials, while Eli Lillys Zepbounda dual GIP/GLP-1 agonistshows approximately 21% weight loss at its highest dose

Other benefits are still emerging and vary in quality

Active Ingredients: Tirzepatide, Vitamin B6 (Pyridoxine) You should not use Tirzepatide if you are allergic to it, or: Let your doctor know if you have ever had: In animal studies, Tirzepatide was shown to cause thyroid cancers or thyroid tumors

Direct oral anticoagulants (DOACs) newer agents including apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa), and edoxaban (Lixiana)